In newly diagnosed breast cancer, screening MRI of the contralateral breast detects mammographically occult cancer, even in elderly women: The Mayo Clinic in Florida experience

Breast Journal

Volumn 16, Issue 2, 2010, Pages 118-126

  Bernard, Johnny Ray ^a   Vallow, Laura A ^a   DePeri, Elizabeth R ^a   McNeil, Rebecca B ^a   Feigel, Deborah G ^a   Amar, Surabhi ^a   Buskirk, Steven J ^a   Perez, Edith A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Breast cancer; Diagnosis; Magnetic resonance imaging

Indexed keywords

ADULT; AGED; AGING; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CLINICAL ARTICLE; CLINICAL EXAMINATION; DIAGNOSTIC ACCURACY; FAMILY HISTORY; FEMALE; GERIATRICS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAMMOGRAPHY; MENOPAUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT CANCER; PREVALENCE; PRIMARY TUMOR; RISK FACTOR; UNITED STATES;

AGED; AGED, 80 AND OVER; BIOPSY; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY;

EID: 77951012671     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2009.00890.x     Document Type: Article

References (54)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96. Epub 2008 Feb 20.
2. Smith RA, Duffy SW, Gabe R, Tabar L, Yen AM, Chen TH. The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am 2004;42:793-806, v.
3. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002;359:909-19. Erratum in: Lancet 2002 Aug 31;360(9334):724.
4. Fracheboud J, Groenewoud JH, Boer R, et al. Seventy-five years is an appropriate upper age limit for population-based mammography screening. Int J Cancer 2006;118:2020-2025
5. Fracheboud J, de Gelder R, Draisma G, Otto SJ, Verbeek ALM, de Koning HJ. Is mammography screening effective up to 75 years? [Abstract] Eur J Cancer Suppl 2008;6:48.
6. Galit W, Green MS, Lital KB. Routine screening mammography in women older than 74 years: a review of the available data. Maturitas 2007;57:109-119 Epub 2007 Mar 1.
7. Badgwell BD, Giordano SH, Duan ZZ, et al. Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol 2008;26:2482-2488 Epub 2008 Apr 21.
8. Kriege M, Brekelmans CT, Boetes C, et al. Magnetic Resonance Imaging Screening Study Group. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004;351:427-437
9. Saslow D, Boetes C, Burke W, et al. American Cancer Society Breast Cancer Advisory Group. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007;57:75-89. Erratum in: CA Cancer J Clin. 2007 May-Jun;57(3):185. (Pubitemid 46535708)
10. Lehman CD, Blume JD, Thickman D, et al. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol 2005;92:9-15.
11. Gutierrez RL, Demartini WB, Eby P, Kurland BF, Peacock S, Lehman CD. Clinical indication and patient age predict likelihood of malignancy in suspicious breast MRI lesions. Acad Radiol 2009;16:1281-1285
12. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999;213:881-888
13. Lee SG, Orel SG, Woo IJ, et al. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology 2003;226:773-778 Epub 2003 Jan 31.
14. Liberman L, Morris EA, Kim CM, et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol 2003;180:333-341 (Pubitemid 36135009)
15. Rieber A, Merkle E, Bohm W, Brambs HJ, Tomczak R. MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma. J Comput Assist Tomogr 1997;21: 773-779
16. Slanetz PJ, Edmister WB, Yeh ED, Talele AC, Kopans DB. Occult contralateral breast carcinoma incidentally detected by breast magnetic resonance imaging. Breast J 2002;8:145-148
17. Viehweg P, Rotter K, Laniado M, et al. MR imaging of the contralateral breast in patients after breast-conserving therapy. Eur Radiol 2004;14:402-408 Epub 2003 Oct 7.
18. Lehman CD, Gatsonis C, Kuhl CK, et al. ACRIN Trial 6667 Investigators Group. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007;356:1295-1303 Epub 2007 Mar 28. (Pubitemid 46513295)
19. Pediconi F, Catalano C, Roselli A, et al. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions. Radiology 2007;243:670-680 Epub 2007 Apr 19.
20. Bilimoria KY, Cambic A, Hansen NM, Bethke KP. Evaluating the impact of preoperative breast magnetic resonance imaging on the surgical management of newly diagnosed breast cancers. Arch Surg 2007;142:441-445
21. Bernard JR, Vallow LA, Packianathan S, Feigel DG, DePeri ER, Perez EA. Mammographically Occult Contralateral Breast Carcinoma Detected by Magnetic Resonance Imaging. [abstract] [Internet]. Poster F-S, p.41. Available at: http://www.asbd.org/images/poster-abstracts-asbd-2007-symposium.pdf (accessed April 8, 2008).
22. Bernard JR Jr, Vallow LA, DePeri ER, et al. Mammographically occult contralateral breast carcinoma detected by magnetic resonance imaging in the elderly [abstract]. J Clin Oncol 2008;26(15S Suppl Pt I):7s.
23. Bernard JR Jr, Vallow LA, Packianathan S, et al. Identification of risk factors in mammographically occult contralateral breast carcinoma detected by magnetic resonance imaging (MRI) [abstract]. J Clin Oncol 2007;25(18S):614.
24. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer: I. the value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-410
25. American College of Radiology. Breast Imaging Reporting and Data System (BI-RADS) Atlas. 4th edn. Reston (VA): American College of Radiology, c2003.
26. Chaudary MA, Millis RR, Hoskins EO, et al. Bilateral primary breast cancer: a prospective study of disease incidence. Br J Surg 1984;71:711-714
27. Roubidoux MA, Helvie MA, Lai NE, Paramagul C. Bilateral breast cancer: early detection with mammography. Radiology 1995;196:427-431
28. Donovan AJ. Bilateral breast cancer. Surg Clin North Am 1990;70:1141-1149
29. Hungness ES, Safa M, Shaughnessy EA, et al. Bilateral synchronous breast cancer: mode of detection and comparison of histologic features between the 2 breasts. Surgery 2000;128:702-707
30. Heron DE, Komarnicky LT, Hyslop T, Schwartz GF, Mansfield CM. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer 2000;88:2739-2750
31. Hartman M, Czene K, Reilly M, et al. Genetic implications of bilateral breast cancer: a population based cohort study. Lancet Oncol 2005;6:377-382
32. Rosen PP, Groshen S, Kinne DW, Hellman S. Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up. Surgery 1989;106:904-910
33. Schootman M, Fuortes L, Aft R. Prognosis of metachronous contralateral breast cancer according to stage at diagnosis: the importance of early detection. Breast Cancer Res Treat 2006;99:91-95 Epub 2006 Mar 23.
34. Leis HP Jr. Managing the remaining breast. Cancer 1980;46(4 Suppl):1026-1030
35. Vallow L, Packianathan S, Feigel D, DePeri E, Buskirk S, Perez EA. Analysis of magnetic resonance imaging (MRI) in the detection of mammographically occult breast carcinoma [abstract]. J Clin Oncol. 2007;25(18S Suppl Pt 1):28s.
36. Vallow LA, Packianathan S, Deperi ER, McDonough MD, Earle JD, Perez EA. Pre-operative breast magnetic resonance imaging (MRI) influences patient selection for partial breast irradiation [abstract]. J Clin Oncol. 2006;24(18S Suppl Pt 1):28s.
37. Houssami N, Hayes DF. Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer? CA Cancer J Clin. 2009;59:290-302. Epub 2009 Aug 13.
38. National Comprehensive Cancer Network. NCCN Clinical Practice Guideline in Oncology: Breast Cancer [Internet]. v2.2.2008. Available at: http://www.nccn.org/professionals/physician-gls/PDF/breast.pdf (accessed February 26, 2008).
39. Betsill WL Jr, Rosen PP, Lieberman PH, Robbins GF. Intraductal carcinoma: long-term follow-up after treatment by biopsy alone. JAMA 1978;239:1863-1867
40. Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 1995;76:1197-1200
41. Fisher B, Bryant J, Dignam JJ, et al. National Surgical Adjuvant Breast and Bowel Project. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 2002;20:4141-4149
42. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-1241
43. Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 2003;98:697-702.
44. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347:1227-1232
45. Berte E, Buzdar AU, Smith TL, Hortobagyi GN. Bilateral primary breast cancer in patients treated with adjuvant therapy. Am J Clin Oncol 1988;11:114-118
46. Rutqvist LE, Cedermark B, Glas U, et al. Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy. J Natl Cancer Inst 1991;83:1299-1306
47. Goldhirsch A, Gelber RD, Castiglione M. Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses. J Clin Oncol 1988;6:89-97.
48. Ruggeri A, Mininberg ED, Valero V, Kau SW, Buzdar AU, Hortobagyi GN. The natural history of metachronous contralateral breast cancer (CBC) in women treated with prior adjuvant or neoadjuvant therapy [abstract] [Internet]. Proc Am Soc Clin Oncol 2003;22. Available at: http://www.asco.org/ASCO/ Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst-detail-view&confID= 23&abstractID=104129 (accessed February 26, 2008).
49. Hankinson SE, Eliassen AH. Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk. J Steroid Biochem Mol Biol 2007;106:24-30. Epub 2007 May 24.
50. Berry DA, Cronin KA, Plevritis SK, et al. Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005;353:1784-1792
51. Arias E. United States life tables, 2004. Natl Vital Stat Rep 2007;56:1-39.
52. American Geriatrics Society Clinical Practice Committee. Breast cancer screening in older women. J Am Geriatr Soc 2000;48: 842-844
53. Smith RA, Saslow D, Sawyer KA, et al. American Cancer Society High-Risk Work Group; American Cancer Society Screening Older Women Work Group; American Cancer Society Mammography Work Group; American Cancer Society Physical Examination Work Group; American Cancer Society New Technologies Work Group; American Cancer Society Breast Cancer Advisory Group. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 2003;53:141-169
54. Schonberg MA, McCarthy EP, Davis RB, Phillips RS, Hamel MB. Breast cancer screening in women aged 80 and older: results from a national survey. J Am Geriatr Soc 2004;52:1688-1695